Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Wistuba

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2014
Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinomaRaphael Bueno, Elisha Hughes, Susanne Wagner, et al.
Archives of Pathology & Laboratory Medicine|August 24, 2012
Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classificationWilliam D Travis, Elisabeth Brambilla, Masayuki Noguchi, et al.
Journal of the National Cancer Institute|April 5, 2017
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung CancerMasanori Kawakami, Lisa Maria Mustachio, Jaime Rodriguez-Canales, et al.
Molecular Cancer Research : MCR|March 1, 2017
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung CancerLisa Maria Mustachio, Yun Lu, Laura J Tafe, et al.
Journal for Immunotherapy of Cancer|February 23, 2022
ISA101 and nivolumab for HPV-16<sup>+</sup> cancer: updated clinical efficacy and immune correlates of responseLuana Guimaraes de Sousa, Kimal Rajapakshe, Jaime Rodriguez Canales, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2016
Validation of SCT Methylation as a Hallmark Biomarker for Lung CancersYu-An Zhang, Xiaotu Ma, Adwait Sathe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2021
Genomic Profiling of Lung Adenocarcinoma in Never-SmokersSiddhartha Devarakonda, Yize Li, Fernanda Martins Rodrigues, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 21, 2015
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 ClassificationWilliam D Travis, Elisabeth Brambilla, Andrew G Nicholson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2019
B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular DensityPhyu P Aung, Edwin Roger Parra, Souptik Barua, et al.
NPJ Breast Cancer|May 9, 2018
A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasisEmily Powell, Jiansu Shao, Hector M Picon, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2014
Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinomaRaphael Bueno, Elisha Hughes, Susanne Wagner, et al.
Archives of Pathology & Laboratory Medicine|August 24, 2012
Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classificationWilliam D Travis, Elisabeth Brambilla, Masayuki Noguchi, et al.
Journal of the National Cancer Institute|April 5, 2017
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung CancerMasanori Kawakami, Lisa Maria Mustachio, Jaime Rodriguez-Canales, et al.
Molecular Cancer Research : MCR|March 1, 2017
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung CancerLisa Maria Mustachio, Yun Lu, Laura J Tafe, et al.
Journal for Immunotherapy of Cancer|February 23, 2022
ISA101 and nivolumab for HPV-16<sup>+</sup> cancer: updated clinical efficacy and immune correlates of responseLuana Guimaraes de Sousa, Kimal Rajapakshe, Jaime Rodriguez Canales, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2016
Validation of SCT Methylation as a Hallmark Biomarker for Lung CancersYu-An Zhang, Xiaotu Ma, Adwait Sathe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2021
Genomic Profiling of Lung Adenocarcinoma in Never-SmokersSiddhartha Devarakonda, Yize Li, Fernanda Martins Rodrigues, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 21, 2015
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 ClassificationWilliam D Travis, Elisabeth Brambilla, Andrew G Nicholson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2019
B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular DensityPhyu P Aung, Edwin Roger Parra, Souptik Barua, et al.
NPJ Breast Cancer|May 9, 2018
A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasisEmily Powell, Jiansu Shao, Hector M Picon, et al.
Pageof 13